Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
805 18 |
Ultima descărcare din IBN: 2021-12-31 10:07 |
Căutarea după subiecte similare conform CZU |
616.4-006.441-071 (3) |
Patologia sistemului limfatic, a organelor hemopoietice şi endocrine (189) |
SM ISO690:2012 BURUIANA, Sanda. Aspecte clinice, hematologice şi imunohistochimice ale limfoamelor non-hodgkin limfocitare din limfocite mici. In: Revista ştiinţifico-practică ”Info-Med” , 2016, nr. 2(28-2), pp. 52-57. ISSN 1810-3936. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista ştiinţifico-practică ”Info-Med” | |||||||
Numărul 2(28-2) / 2016 / ISSN 1810-3936 | |||||||
|
|||||||
CZU: 616.4-006.441-071 | |||||||
Pag. 52-57 | |||||||
|
|||||||
Descarcă PDF | |||||||
Rezumat | |||||||
The clinical, hematologic and immunohistochemical aspects of non-Hodgkin’s lymphomas were studied in a group of 28 patients with the age range of 37-71 years old. The disease developed and prevailed in patients over 50 years old. The diagnosis was established by morphologic and immunohistochemical analyses, which proved to be CD19, CD20,CD5 and CD23 – pozitive. The primary tumor focus developed more frequently in the peripheral lymph nodes (50,0%) and in spleen (32,2%). During the generalization the bone marrow was frequently impaired (95%). In the majority of cases the IPI values were of highly negative risk and correlated with the survival rates, which constituted 87.3% within 3 years and 65.1% within 5 years. |
|||||||
Cuvinte-cheie non-Hodgkin’s lymphoma, immunohistochemistry, clinical, hematological |
|||||||
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <creators> <creator> <creatorName>Buruiana, S.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> </creators> <titles> <title xml:lang='ro'>Aspecte clinice, hematologice şi imunohistochimice ale limfoamelor non-hodgkin limfocitare din limfocite mici</title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2016</publicationYear> <relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1810-3936</relatedIdentifier> <subjects> <subject>non-Hodgkin’s lymphoma</subject> <subject>immunohistochemistry</subject> <subject>clinical</subject> <subject>hematological</subject> <subject schemeURI='http://udcdata.info/' subjectScheme='UDC'>616.4-006.441-071</subject> </subjects> <dates> <date dateType='Issued'>2016-11-22</date> </dates> <resourceType resourceTypeGeneral='Text'>Journal article</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'>The clinical, hematologic and immunohistochemical aspects of non-Hodgkin’s lymphomas were studied in a group of 28 patients with the age range of 37-71 years old. The disease developed and prevailed in patients over 50 years old. The diagnosis was established by morphologic and immunohistochemical analyses, which proved to be CD19, CD20,CD5 and CD23 – pozitive. The primary tumor focus developed more frequently in the peripheral lymph nodes (50,0%) and in spleen (32,2%). During the generalization the bone marrow was frequently impaired (95%). In the majority of cases the IPI values were of highly negative risk and correlated with the survival rates, which constituted 87.3% within 3 years and 65.1% within 5 years. </description> <description xml:lang='ru' descriptionType='Abstract'>Были рассмотрены клинические, гематологические и иммуногистохимическое анализы 28 пациентов с неходжкинской лимфомой (НХЛ), малых лимфоцитов 37 лет до 71 лет. Болезнь была разработана преобладая у взрослых и у людей в возрасте старше 50 лет (89,3%). Диагноз был подтвержден и иммуногистохимические показатели CD19, CD20, CD5 и CD23 были положительными. Первичная опухоль чаще вырастает в лимфатических узлах (50,0%) и селезенки (32,2%). При постановке диагноза преобладали обобщенные стадии заболевания. В ходе обобщения часто была затронута кости (95%). IPI в большинстве случаев был высокий риск и отрицательно коррелирует с выживаемостью что намекает на то что в течение 3-х лет было 87,3%, а за 5 лет - 65,1%. </description> </descriptions> <formats> <format>application/pdf</format> </formats> </resource>